Sort
326,823 grants matching “clinical trial”
WHI Sequencing Project (WHISP)
$2,411,094Rebecca D Jackson · Ohio State University · UC2 · FY2010 · HL
Reducing Chronic Pain and Opioid Use in Hemodialysis Patients
$2,411,041Sahir Kalim · Massachusetts General Hospital · U01 · FY2019 · DK
Rustbelt Center for AIDS Research (Case/UHC-Pitt CFAR)
$2,411,000Jonathan Karn · Case Western Reserve University · P30 · FY2022 · AI
Rustbelt Center for AIDS Research (Case/UHC-Pitt CFAR)
$2,411,000Jonathan Karn · Case Western Reserve University · P30 · FY2023 · AI
Utility of Random Biopsies in Inflammatory Bowel Disease
$2,410,980James D Lewis · University Of Pennsylvania · U01 · FY2024 · DK
Pharmacokinetics and Drug Metabolism
$2,410,920Xin Xu · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Integration of Whole Genome Sequencing into Clinical Medicine
$2,410,752Robert C. Green · Brigham And Women'S Hospital · U01 · FY2012 · HG
Phase 1b first-in-patient safety trial for CT1812, a novel Alzheimerâs synaptic protection therapeutic
$2,410,669Susan M Catalano · Cognition Therapeutics, Inc. · RF1 · FY2016 · AG
Phase 1 safety trial for CT1812, a novel small molecule therapeutic targeting a synaptic receptor for Abeta oligomers
$2,410,669Susan M Catalano · Cognition Therapeutics, Inc. · RF1 · FY2016 · AG
Cancer Center Support Grant
$2,410,577Michael J Weber · University Of Virginia · P30 · FY2009 · CA
Cancer Center Support Grant
$2,410,577Michael J Weber · University Of Virginia · P30 · FY2008 · CA
Cancer Center Support Grant
$2,410,577Michael J Weber · University Of Virginia · P30 · FY2007 · CA
Cancer Center Support Grant
$2,410,577Michael J Weber · University Of Virginia · P30 · FY2010 · CA
CORE NICHD NETWORK CLINICAL SITE SUPPORT FOR IMPAACT RELATED STUDIES
$2,410,479Barbara Driver · Westat, Inc. · N01 · FY2021 · HD
Community Clinical Oncology Program
$2,409,977Charles L Loprinzi · Mayo Clinic Rochester · U10 · FY2011 · CA
Stop Atherosclerosis in Native Diabetics study (SANDS)
$2,409,835Medstar Research Institute · U01 · FY2002 · HL
Scientific innovation for personalized severe asthma management
$2,409,373Benjamin M Gaston · Indiana University Indianapolis · P01 · FY2022 · HL
Biomarker Rich Clinical Trial of an Innovative Antibody Antagonist of TNFR2 in Non-Hodgkin Lymphoma Featuring Cutaneous T Cell Lymphoma (CTCL).
$2,409,283David G Brooks · Boston Immune Technologies And Therapeutics, Inc. · R44 · FY2025 · CA
Wisconsin NCI Community Oncology Research Program (WiNCORP)
$2,409,250Adedayo A Onitilo · Marshfield Clinic Research Foundation · UG1 · FY2019 · CA
CP-CTNet Coordinating Center Year 6 - Aug 1, 2024 through July 31, 2025
$2,409,242Jens Eickhoff · University Of Wisconsin-Madison · U24 · FY2024 · CA
Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases
$2,409,113John McLeod Griffiss · Icon Government And Public Health Solutions, Inc. · N01 · FY2014 · AI
Genetic Basis Of Cortical Malfunction In Schizophrenia
$2,409,110Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2012 · MH
Development of Novel Therapeutic Strategies in Human Leukemias
$2,408,966James D Griffin · Dana-Farber Cancer Inst · P01 · FY2010 · CA
Alliance Grant Year 9 BIQSFP Supplements
$2,408,803Steven Piantadosi · Brigham And Women'S Hospital · U10 · FY2022 · CA
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)
$2,408,741Payam Nahid · University Of California, San Francisco · R01 · FY2025 · AI